Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Point Of Care Hematology Diagnostics Market size between 2026 and 2035?
The point of care hematology diagnostics market has demonstrated significant expansion in recent years. Its size is expected to increase from $2.9 billion in 2025 to $3.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. This historical growth can be attributed to several factors, including a reliance on centralized laboratory testing, the increasing prevalence of anemia and blood disorders, a rise in hospital emergency admissions, the demand for quicker diagnostic results, and restricted access to laboratory infrastructure in rural areas.
The point of care hematology diagnostics market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach $4.39 billion, exhibiting a compound annual growth rate (CAGR) of 8.6%. This projected growth is driven by several factors, including the increasing incidence of chronic and infectious diseases, the expansion of point-of-care testing initiatives, a heightened need for swift diagnostic solutions in emergency settings, innovations in compact hematology analyzers, and the expansion of decentralized healthcare delivery models. Key trends shaping the market during this period encompass the increasing acceptance of rapid bedside blood testing, a rising need for decentralized diagnostics in urgent care situations, the broader implementation of portable and handheld hematology devices, the spread of point-of-care testing into regions with limited resources, and an emphasis on achieving quicker turnaround times for informed clinical decisions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27388&type=smp
Which Drivers Are Impacting Market Performance In The Point Of Care Hematology Diagnostics Market?
The anticipated expansion of the point-of-care hematology diagnostics market going forward is propelled by the increasing prevalence of blood disorders. These conditions specifically affect components of blood, including red blood cells, white blood cells, platelets, or plasma. A primary cause of the rising incidence of blood disorders is the growing occurrence of chronic diseases, which directly influence blood health and necessitate ongoing monitoring. Point-of-care hematology diagnostics assist in the timely detection and monitoring of these disorders by providing rapid, accurate results at or near the patient’s care site, facilitating quicker clinical decisions and improved disease management. For instance, in November 2024, The American Society of Hematology, a US-based Non-profit organization, projected that global leukemia cases could increase to approximately 519,540 by 2050. Therefore, the rising incidence of blood disorders is a significant factor driving the growth of the point-of-care hematology diagnostics market.
What Segment Types Are Examined In The Point Of Care Hematology Diagnostics Market?
The point of care hematology diagnostics market covered in this report is segmented –
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
3) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users
Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing
How Are Emerging Trends Affecting The Progression Of The Point Of Care Hematology Diagnostics Market?
Leading companies active in the point-of-care hematology diagnostics market are concentrating on developing technologically advanced products, such as cartridge-based AI-powered hematology analyzers, to offer rapid, accurate, and on-site blood analysis for improved patient care. Cartridge-based AI-powered hematology analyzers are compact diagnostic instruments that utilize single-use reagent cartridges and artificial intelligence algorithms to quickly and precisely analyze blood samples at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer designed for veterinary use. This innovative system provides rapid, reference laboratory-quality complete blood count (CBC) results within minutes at the point of care, concurrently reducing maintenance and hands-on time. It is equipped with advanced AI-driven image analysis and viscoelastic focusing technology that accurately aligns cells for clear imaging, enabling precise blood cell classification and automated abnormality detection, thereby ensuring efficient and reliable veterinary diagnostics.
Who Are The Major Companies Operating In The Point Of Care Hematology Diagnostics Market?
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Point Of Care Hematology Diagnostics Market?
North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point Of Care Hematology Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27388&type=smp
Browse Through More Reports Similar to the Global Point Of Care Hematology Diagnostics Market 2026, By The Business Research Company
Architectural And Structural Metals Global Market Report 2026
Architectural And Structural Metals Global Market Report 2026
Buildings Construction Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/buildings-construction-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company